Tricks played by certain disease-driving gut bacteria might help explain differences in how patients experience Crohn's disease (CD)—a severe and painful chronic inflammatory bowel disease. A new study by researchers from ...
Mar 13, 2024
0
26
In recent years, the treatment landscape for solid tumors has undergone a notable change. With new cancer treatments, the future looks brighter for many young cancer patients, making fertility issues and future family planning ...
Mar 13, 2024
0
0
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this ...
Mar 12, 2024
0
101
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
This week, Western Australia announced a state government-funded immunization program against respiratory syncytial virus (RSV). It's the first Australian state or territory to do so.
Mar 7, 2024
0
0
Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk—and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute ...
Mar 4, 2024
1
32
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study presenting ...
Mar 4, 2024
0
0
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein ...
Mar 1, 2024
0
50
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has successfully developed a neutralizing monoclonal antibody, 6H2, which targets a harmful protein known to exacerbate damage caused ...
Feb 27, 2024
0
0
A long-term analysis conducted by leading microbiologists at the Icahn School of Medicine at Mount Sinai reveals that antibody responses induced by COVID-19 vaccines are long-lasting. The study results, published online in ...
Feb 26, 2024
0
55
